STOCK TITAN

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Avadel Pharmaceuticals plc (Nasdaq: AVDL) will host a conference call and webcast on November 8, 2023, to provide a corporate update and discuss the financial results for Q3 2023. The call can be accessed on the company's website and a replay will be available for 90 days.
Positive
  • None.
Negative
  • None.

DUBLIN, Ireland, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 8, 2023, to provide a corporate update and discuss the Company's financial results for the third quarter ended September 30, 2023.

A live audio webcast of the call be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event. Participants may register for the conference call here and are advised to do so at least 10 minutes prior to joining the call.

About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZTM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162


FAQ

When will Avadel Pharmaceuticals host the conference call and webcast?

Avadel Pharmaceuticals will host the conference call and webcast on November 8, 2023.

What is the purpose of the conference call and webcast?

The conference call and webcast will provide a corporate update and discuss the financial results for the third quarter of 2023.

Where can the conference call and webcast be accessed?

The call can be accessed by visiting the investor relations section of Avadel Pharmaceuticals' website, www.avadel.com.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be archived on Avadel's website for 90 days following the event.

How can participants register for the conference call?

Participants can register for the conference call by visiting the provided link and are advised to do so at least 10 minutes prior to joining the call.

Avadel Pharmaceuticals plc Ordinary Share

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Stock Data

1.81B
66.69M
4.9%
64.09%
11.48%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
DUBLIN

About AVDL

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.